BIRT-377
CAS No. 213211-10-0
BIRT-377( BIRT 377 | BIRT377 )
Catalog No. M27754 CAS No. 213211-10-0
BIRT-377 is a negative allosteric LFA-1 modulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 116 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 432 | In Stock |
|
| 50MG | 625 | In Stock |
|
| 100MG | 889 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBIRT-377
-
NoteResearch use only, not for human use.
-
Brief DescriptionBIRT-377 is a negative allosteric LFA-1 modulator.
-
DescriptionBIRT-377 is a negative allosteric LFA-1 modulator.
-
In Vitro——
-
In Vivo——
-
SynonymsBIRT 377 | BIRT377
-
PathwayOthers
-
TargetOther Targets
-
Recptorβ-D-glucosidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number213211-10-0
-
Formula Weight442.13
-
Molecular FormulaC18H15BrCl2N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (226.18 mM)
-
SMILESCN1C(=O)N(C(=O)[C@@]1(C)Cc1ccc(Br)cc1)c1cc(Cl)cc(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Puri M, et, al. Production, purification, and characterization of the debittering enzyme naringinase. Biotechnol Adv. 2000 May;18(3):207-17.
molnova catalog
related products
-
ACTH?(7-38) (human)
ACTH (7-38) (human) is the 7-38 fragment of human ACTH (1-39). human ACTH (1-39), known as a corticotropin inhibitory peptide (CIP), is an antagonist of the ACTH receptor and has no any corticosteroid activity.
-
HQL-79
HQL-79, a potent, selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor, highly selectively inhibits the synthesis of PGD2, and acts as an anti-allergic agent, with a Kd of 0.8 μM and an IC50 of 6 μM. Shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS.
-
2-Hydroxybenzimidazo...
2-Hydroxybenzimidazole is used as an intermediate in industry.
Cart
sales@molnova.com